NOhep stories winners announced

We are delighted to announce the top ten finalists from our NOhep stories contest. The stories illustrate the global impact that hepatitis is having on people and communities worldwide.

The stories contest was a collaboration between the NOhep movement, the World Hepatitis Alliance (WHA) and the London School of Hygiene and Tropical Medicine (LSHTM) with funding from Endhep2030, The Hepatitis Fund.

Dr Joe Tucker from LSHTM said: “These stories are an incredible reminder of the global impact of hepatitis. Our aim is that these stories will remind policy makers on the need to take action so that we can reach the elimination of viral hepatitis by 2030.”


The top ten submissions were:

  • “Family diary beating hepatitis B” – an infographic from China
  • “Let’s not whisper, let’s speak loudly and openly about who we are, how we feel, and lend a hand to the others like us” – Silvana Lesidrenska- Bulgaria
  • “Tackling hepatitis and COVID-19” a video from Yiyou Charity Liver Center and Yiyou Aigan Public Welfare Development Center, Yuexiu District, Guangzhou- China
  • “My hepatitis C journey” Dr Evelyn McKnight- USA
  • “Faces of hepatitis C” Asociación Civil Buena Vida – Argentina
  • “The story of Muslima Kader Mili”- a video from the National liver Foundation of Bangladesh – Bangladesh
  • “How to prevent hepatitis B in newborns” an infographic from Wu Nan from the Institute of Liver Diseases, First Affiliated Hospital of Peking University
  • “The Contribution of the NGO ASOJEDEC in the establishment of a national programme to fight viral hepatitis”- Democratic Republic of Congo
  • “A call to action from Bralise, a young advocate” – Democratic Republic of Congo
  • “The personal story of Aleksey Lakhov”- Russia


Winning submissions will be awarded prizes and the stories will be used to encourage policy makers to prioritise hepatitis elimination efforts. Participants will also have the opportunity to share their experiences at international meetings.

Sign up to receive updates from WHA

Name(Required)
I would like to hear about(Required)

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Hepatitis and PWID/harm reduction 

 

11:35 – 11:40  

Chair: WHO – Intro and set the scene.  

 

11:40 – 11:55  

Co-chair:  EMCDDA – Monitoring viral hepatitis elimination among PWID in Europe. 

 

11:55 – 12:00 

ID 29: Ema Pos (not yet registered) 

Title: If the mountain won’t come to Mohammed: lessons from a decentralized Infectious Disease consultation. 

 

12:05 – 12:10  

ID 152: Brian Conway (Registered in person) 

Title: Community Pop-up Clinic: Cascade of Care and HCV Treatment of Vancouver’s inner-city PWID Populations.

 

12:10 – 12:15 

ID 212: Jasmine West (not yet registered) 

Title: From lived experience to lived expertise: a syndemic approach. 

 

12:15 – 12:20 

ID: 299 Mercy Nyakowa (Registered in person) 

Title: HCV and HBV prevalence and associated risk factors among people who inject drugs (PWIDs) in Kenya 

 

12:20 – 12:25 

ID: 133 Nalinikanta Rajkumar (Registered in person) 

Title: Rapid regimen of HBV vaccination: Does it work for high risk groups?  

 

12:25 – 12:30 

Q&A and closing remarks   

tHIS

 

IS 

 

BEN’S

 

 

 

BIG 

 

 

TEST

effective case finding strategies

Supported by Vir Biotechnology, Inc

During this session you will hear from hepatitis Delta expert, Dr. Maria Buti, and a patient who has lived with hepatitis Delta in a panel discussion moderated by Dr. Carey Hwang, Chief Medical Officer (interim) of Vir Biotechnology. This panel will inform perspectives on patient needs, opportunities for enhanced screening, and strengthening linkages to care.

Session Agenda

14:40 – 14:45    

Panel overview and introductions facilitated by Dr Carey Hwang (Vir Biotechnology)

14:45 – 15:05   

Panel discussion: Dr Maria Buti (University Hospital Vall d’Hebron, Spain), Milanka Barbosa, Dr Carey Hwang (Chief Medical Officer interim), Vir Biotechnology

15:05 – 15:10    

Final remarks and close